13h
Insurance data can help fill gaps between longer medical trials for patients up against the clock
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
New evidence hints that statins may protect a wider range of people with type 2 diabetes than previously assumed. A major ...
Why lasting weight maintenance requires more than calorie control, integrating diet quality, movement, circadian biology, ...
MedPage Today on MSN
DVT Assessment Strategy Safely Expands Rule-Out
A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more ...
Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approvalInitiation of the ...
News-Medical.Net on MSN
AI language models actually help in digestive disease care
Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...
By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...
A new Divinity AMA with developer Larian Studios discusses use of generative-AI tools in development, lessons from BG3, and ...
By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of fighting cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback